Skip to main navigation Skip to search Skip to main content

Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure

Palle B Jeppesen, Marek Pertkiewicz, Bernard Messing, Kishore Iyer, Douglas L Seidner, Stephen J D O'keefe, Alastair Forbes, Hartmut Heinze, Bo Joelsson

    456 Citations (Scopus)

    Abstract

    Teduglutide, a glucagon-like peptide 2 analogue, might restore intestinal structural and functional integrity by promoting growth of the mucosa and reducing gastric emptying and secretion. These factors could increase fluid and nutrient absorption in patients with short bowel syndrome with intestinal failure (SBS-IF). We performed a prospective study to determine whether teduglutide reduces parenteral support in patients with SBS-IF.
    Original languageEnglish
    JournalGastroenterology
    Volume143
    Issue number6
    Pages (from-to)1473-1481.e3
    Number of pages9
    ISSN0016-5085
    DOIs
    Publication statusPublished - 2012

    Fingerprint

    Dive into the research topics of 'Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure'. Together they form a unique fingerprint.

    Cite this